Dolby Laboratories (NYSE:DLB) Updates Q2 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its second quarter 2026 earnings guidance on Friday. The company provided EPS guidance of 1.290-1.440 for the period, compared to the consensus EPS estimate of 1.240. The company issued revenue guidance of $375.0 million-$405.0 million, compared to the consensus revenue estimate of $380.6 million. Dolby Laboratories also updated its FY 2026 guidance to 4.300-4.450 EPS.

Wall Street Analysts Forecast Growth

DLB has been the subject of several recent analyst reports. Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Thursday, January 22nd. Barrington Research reduced their price objective on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research report on Monday. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Finally, Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Monday, January 5th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $90.75.

Dolby Laboratories Trading Up 2.8%

Shares of Dolby Laboratories stock opened at $62.89 on Friday. The business has a fifty day simple moving average of $65.14 and a two-hundred day simple moving average of $68.95. The firm has a market capitalization of $6.01 billion, a P/E ratio of 23.91 and a beta of 0.88. Dolby Laboratories has a 12 month low of $60.14 and a 12 month high of $89.66.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business had revenue of $307.02 million for the quarter, compared to analysts’ expectations of $305.76 million. During the same period in the prior year, the firm posted $0.61 EPS. The firm’s quarterly revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio is presently 54.75%.

Insiders Place Their Bets

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 6,751 shares of the company’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.24, for a total value of $453,937.24. Following the transaction, the chief executive officer directly owned 98,377 shares in the company, valued at $6,614,869.48. This represents a 6.42% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Mark Andrew Sherman sold 2,491 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $67.26, for a total transaction of $167,544.66. Following the transaction, the executive vice president owned 70,563 shares in the company, valued at approximately $4,746,067.38. This represents a 3.41% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 137,120 shares of company stock valued at $9,184,809 over the last quarter. 37.93% of the stock is currently owned by insiders.

Key Stories Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Dolby raised FY?2026 and Q2 guidance well above prior Street expectations — management now targets FY EPS roughly in the mid?$4s and Q2 EPS of $1.29–$1.44, with revenue ranges above consensus. This is the main bullish catalyst supporting upside conviction. PR Newswire: Dolby Laboratories Reports First Quarter 2026 Financial Results
• Positive Sentiment: Q1 results beat headline estimates: revenue ~$346.7M and EPS $1.06 topped consensus, showing resilience in top?line and headline profitability versus forecasts. Beating the print supported management’s confidence in the outlook. MarketBeat: Q1 results summary
• Positive Sentiment: Street reaction includes at least one analyst upgrade and commentary that Dolby’s valuation looks more attractive after the quarter, which can support positive analyst momentum and higher price targets. Seeking Alpha: Rating upgrade
• Neutral Sentiment: Management commentary and the earnings?call transcript highlight confidence in content partnerships and product roadmaps; investors can review the call transcript/highlights for detail on customer wins, product mix and margin cadence. Yahoo Finance: Q1 highlights
• Negative Sentiment: Third?party coverage flagged weaker operating profitability and cash?flow metrics in the quarter (lower operating profit, declining operating cash flow in certain reports), which prompted some short?term selling after the release. That mixed internal sizing of growth vs. margin pressure is weighing on the stock. QuiverQuant: Mixed metrics & stock reaction
• Negative Sentiment: Earlier analyst downgrades and a recent one?year low callout have kept downward pressure on sentiment; investors sensitive to near?term multiples or margin volatility may remain cautious. American Banking News: 1?year low on downgrade

Institutional Trading of Dolby Laboratories

Hedge funds and other institutional investors have recently made changes to their positions in the company. Royal Bank of Canada boosted its position in shares of Dolby Laboratories by 3.5% during the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock worth $5,491,000 after purchasing an additional 2,298 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Dolby Laboratories by 218.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after buying an additional 171,288 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Dolby Laboratories by 5.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock valued at $19,131,000 after buying an additional 12,598 shares in the last quarter. Focus Partners Wealth acquired a new position in shares of Dolby Laboratories during the first quarter worth about $390,000. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Dolby Laboratories by 273.3% in the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock valued at $193,000 after purchasing an additional 1,902 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.